POSTER SESSION III Tuesday, March 25, 2003   —  9:30 AM - 12:00 Noon Exhibit Hall A - C LIVER AND PANCREAS PATHOLOGY 158 Histologic Evaluation of the Effectiveness of Radio Frequency Ablation of Hepatocellular Carcinoma (HCC) Prior to Liver Transplantation (1234) B Altrabulsi, R Goldstein, M Levy, E Sanchez, D Watkins, G Klintmalm, G Netto Baylor University Medical Center, Dallas, TX 159 Analysis of Antioxidant Enzymes in Hepatocellular Carcinomas and Adjacent Liver in Fatty acyl-CoA Oxidase Deficient Mice, a Model of Spontaneous Hepatocarcinogenesis (1269) P Kashireddy, K Meyer, MS Rao The Feinberg School of Medicine, Northwestern University, Chicago, IL 160 Aberrant CpG Island Hypermethylation along Multistep Hepatocarcinogenesis (1277) S Lee, H-S Lee, GH Kang National Cancer Center, Ilsan; Seoul National University College of Medicine, Seoul, Korea 161 Evaluation of Sensitivity of CD10 Expression in the Diagnosis of Hepatocellular Carcinoma (1256) R Gupta, M Abecassis, MS Rao Feinberg School of Medicine, Northwestern University, Chicago, IL 162 Immunophenotyping in Sinusoidal Elements in Hepatocellular Carcinogenesis (1252) FM Graeme-Cook, GY Lauwers, DE Eatherton, M Mino Massachusetts General Hospital, Boston, MA 163 Survivin Is Overexpressed in a Subset of Hepatocellular Carcinomas (1313) J Wang, Q Liu, M Torbenson University of Oklahoma, Oklahoma City, OK; Johns Hopkins, Baltimore, MD 164 CEACAM1, a CEA Related Cell Adhesion Molecule, Is Down-Regulated in Hepatocellular Carcinoma (1301) SS Shen, A Rashid, JR Tunstead, S-H Lin Baylor College of Medicine, Houston, TX; UT-M.D. Anderson Cancer Center, Houston, TX 165 Targeted Use of Gene Chip Microarrays To Identify Potential Oncogenes in Hepatocellular Carcinomas (1305) M Torbenson, F Sahin, A Klein, L Arrazola, E Molmenti, M Choti, K Berg Johns Hopkins Hospital, Baltimore, MD 166 Presence of Alpha-methylacyl-CoA Racemase in Liver Lesions (1308) M Turkyilmaz, M Tretiakova, J Davison, C Gong, X Yang, J Hart The University of Chicago, Chicago, IL; John Hopkins, Baltimore, MD 167 Activation of the TGF-Beta Signaling Pathway Is Associated with Bax Protein over Expression in Hepatocellular Carcinoma (1293) W Qui, R Ashfaq, D Dang, R Wilentz, GH Su, M Torbenson Johns Hopkins Hospital, Baltimore, MD; University of Texas Southwestern, Dallas, TX 168 Promoter Methylation of Tumor Suppressor Genes in Hepatic Adenoma and Focal Nodular Hyperplasia (1315) B Yang, M Guo, R Patel, JG Herman, DP Clark, JR Goldblum Johns Hopkins Medical Institutions, Baltimore, MD; Cleveland Clinic Foundation, Cleveland, OH 169 Immunohistochemical Analysis of Embryonal Sarcoma of the Liver (1244) WL Frankel, B Kiani, LD Ferrell, S Qualman The Ohio State University Medical Center, Columbus, OH; University of California San Francisco, San Francisco, CA; Children's Hopital, Columbus, OH 170 Telomere Length Variation in Biliary Tract Metaplasia, Dysplasia and Carcinoma (546) DE Hansel, AK Meeker, KD Lillemoe, R Shulick, RH Hruban, A Maitra, P Argani The Johns Hopkins University School of Medicine, Baltimore, MD 171 Diagnostic Value of B-Catenin,CK-20 and MUC-2 Immunohistochemical Expression in Discriminating between Hepatocellular Carcinoma (HCC), Cholangiocarcioma (CC) and Metatatic Colorectal Adenocarcinoma (MCA) of the Liver (1279) HH Mady, MM Awad, MF Melhem Veterans Affairs Healthcare System, Pittsburgh, PA; University of Pittsburgh School of Medicine, Pittsburgh, PA; Suez Canal University, Ismailia, Egypt 172 Utility of CDX2 Immunoreactivty in the Diagnosis of Metastatic Adenocarcinoma to the Liver (1246) A Furlanetto, E Orvieto, L Laurino, AP Dei Tos Regional Hospital, Treviso, Italy 173 Hepatocyte Antigen and CD10 in Primary and Metastatic Carcinomas of the Liver: A Comparison to Alpha-Fetoprotein (AFP), CK7 and CK20 (1294) HS Qureshi, O Alassi, AH Ormsby, MD Linden, G Divine, CK Ma Henry Ford Hospital, Detroit, MI